Cellular effects of helium in different organs

Anesthesiology

Volumn 112, Issue 6, 2010, Pages 1503-1510

  Oei, Gezina T M L ^a   Weber, Nina C ^a   Hollmann, Markus W ^b   Preckel, Benedikt ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE RECEPTOR; ALPHA ADRENERGIC RECEPTOR; ARGON; BRADYKININ RECEPTOR; CYCLOOXYGENASE 2; DESFLURANE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLYCOGEN SYNTHASE KINASE 3BETA; HELIUM; INHALATION ANESTHETIC AGENT; ISOFLURANE; KRYPTON; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MUSCARINIC RECEPTOR; NEON; OPIATE RECEPTOR; OXYGEN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; S6 KINASE; SEVOFLURANE; XENON;

ANTIINFLAMMATORY ACTIVITY; BRAIN ISCHEMIA; BRAIN PROTECTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG POTENCY; DRUG TARGETING; GENERAL ANESTHESIA; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; MULTIPLE CYCLE TREATMENT; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; TRAUMATIC BRAIN INJURY;

EID: 77953026048     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3181d9cb5e     Document Type: Review

References (72)

1. Lango T, Morland T, Brubakk AO: Diffusion coefficients and solubility coefficients for gases in biological fluids and tissues: A review. Undersea Hyperb Med 1996; 23:247-272
2. Koblin DD, Fang Z, Eger EI II, Laster MJ, Gong D, Ionescu P, Halsey MJ, Trudell JR: Minimum alveolar concentrations of noble gases, nitrogen, and sulfur hexafluoride in rats Helium and neon as nonimmobilizers (nonanesthetics). Anesth Analg 1998; 87:419-424
3. Harris PD, Barnes R: The uses of helium and xenon in current clinical practice. Anaesthesia 2008; 63:284-293
4. Singer D: Why 37 degrees C? Evolutionary fundamentals of thermoregulation. Anaesthesist 2007; 56:899-906
5. David HN, Haelewyn B, Chazalviel L, Lecocq M, Degoulet M, Risso JJ, Abraini JH: Post-ischemic helium provides neuroprotection in rats subjected to middle cerebral artery occlusion-induced ischemia by producing hypothermia. J Cereb Blood Flow Metab 2009; 29:1159-1165
6. Hess DR, Fink JB, Venkataraman ST, Kim IK, Myers TR, Tano BD: The history and physics of heliox. Respir Care 2006; 51:608-612
7. Little HJ: How has molecular pharmacology contributed to our understanding of the mechanism(s) of general anesthesia? Pharmacol Ther 1996; 69:37-58
8. Lawrence JH, Loomis WF, Tobias CA, Turpin FH: Preliminary observations on the narcotic effect of xenon with a review of values for solubilities of gases in water and oils. J Physiol 1946; 105:197-204
9. Cullen SC, Gross EG: The anesthetic properties of xenon in animals and human beings, with additional observations on krypton. Science 1951; 113:580-582
10. Brauer RW, Hogan PM, Hugon M, Macdonald AG, Miller KW: Patterns of interaction of effects of light metabolically inert gases with those of hydrostatic pressure as such: A review. Undersea Biomed Res 1982; 9:353-396
11. Lever MJ, Miller KW, Paton WD, Smith EB: Pressure reversal of anaesthesia. Nature 1971; 231:368-371
12. Hausenloy DJ, Yellon DM: Preconditioning and postcondi-tioning: Underlying mechanisms and clinical application. Atherosclerosis 2009; 204:334-341
13. Weber NC, Schlack W: Inhalational anaesthetics and car-dioprotection. Handb Exp Pharmacol 2008; 182:187-207
14. Weber NC, Preckel B, Schlack W: The effect of anaesthetics on the myocardium: New insights into myocardial protection. Eur J Anaesthesiol 2005; 22:647-657
15. Toma O, Weber NC, Wolter JI, Obal D, Preckel B, Schlack W: Desflurane preconditioning induces time-dependent activation of protein kinase C epsilon and extracellular signal-regulated kinase 1 and 2 in the rat heart in vivo. ANESTHESIOLOGY 2004; 101:1372-1380
16. Weber NC, Toma O, Wolter JI, Obal D, Mullenheim J, Preckel B, Schlack W: The noble gas xenon induces pharmacological preconditioning in the rat heart in vivo via induction of PKC-epsilon and p38 MAPK. Br J Pharmacol 2005; 144:123-132
17. Weber NC, Stursberg J, Wirthle NM, Toma O, Schlack W, Preckel B: Xenon preconditioning differently regulates p44/42 MAPK (ERK 1/2) and p46/54 MAPK (JNK 1/2 and 3) in vivo. Br J Anaesth 2006; 97:298-306
18. Pagel PS, Krolikowski JG, Shim YH, Venkatapuram S, Ker-sten JR, Weihrauch D, Warltier DC, Pratt PFJ: Noble gases without anesthetic properties protect myocardium against infarction by activating prosurvival signaling kinases and inhibiting mitochondrial permeability transition in vivo. Anesth Analg 2007; 105:562-569
19. Pagel PS, Krolikowski JG, Pratt PFJ, Shim YH, Amour J, Warltier DC, Weihrauch D: Inhibition of glycogen syn-thase kinase or the apoptotic protein p53 lowers the threshold of helium cardioprotection in vivo: The role of mitochondrial permeability transition. Anesth Analg 2008; 107:769-775
20. Pagel PS, Krolikowski JG, Amour J, Warltier DC, Weihrauch D: Morphine reduces the threshold of helium preconditioning against myocardial infarction: The role of opioid receptors in rabbits. J Cardiothorac Vasc Anesth 2009; 23:619-624
21. Halestrap AP, Clarke SJ, Khaliulin I: The role of mitochondria in protection of the heart by preconditioning. Bio-chim Biophys Acta 2007; 1767:1007-1031
22. Nishihara M, Miura T, Miki T, Tanno M, Yano T, Naitoh K, Ohori K, Hotta H, Terashima Y, Shimamoto K: Modulation of the mitochondrial permeability transition pore complex in GSK-3beta-mediated myocardial protection. J Mol Cell Cardiol 2007; 43:564-570
23. Cohen MV, Yang XM, Downey JM: The pH hypothesis of postconditioning: Staccato reperfusion reintroduces oxygen and perpetuates myocardial acidosis. Circulation 2007; 115:1895-1903
24. Pagel PS, Krolikowski JG: Transient metabolic alkalosis during early reperfusion abolishes helium preconditioning against myocardial infarction: Restoration of cardioprotec-tion by cyclosporin A in rabbits. Anesth Analg 2009; 108: 1076-1082
25. Heinen A, Huhn R, Smeele KM, Zuurbier CJ, Schlack W, Preckel B, Weber NC, Hollmann MW: Helium-induced preconditioning in young and old rat heart: Impact of mitochondrial Ca(2+)-sensitive potassium channel activation. ANESTHESIOLOGY 2008; 109:830-836
26. Pagel PS, Krolikowski JG, Pratt PFJ, Shim YH, Amour J, Warltier DC, Weihrauch D: The mechanism of helium-induced preconditioning: A direct role for nitric oxide in rabbits. Anesth Analg 2008; 107:762-768
27. Pagel PS, Krolikowski JG, Pratt PFJ, Shim YH, Amour J, Warltier DC, Weihrauch D: Reactive oxygen species and mitochondrial adenosine triphosphate-regulated potassium channels mediate helium-induced preconditioning against myocardial infarction in vivo. J Cardiothorac Vasc Anesth 2008; 22:554-559
28. Huhn R, Heinen A, Weber NC, Kerindongo RP, Oei GT, Hollmann MW, Schlack W, Preckel B: Helium-induced early preconditioning and postconditioning are abolished in obese Zucker rats in vivo. J Pharmacol Exp Ther 2009; 329:600-607
29. Ferdinandy P, Schulz R, Baxter GF: Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev 2007; 59:418-458
30. Zucker LM, Antoniades HN: Insulin and obesity in the Zucker genetically obese rat "fatty." Endocrinology 1972; 90:1320-1330
31. Mio Y, Bienengraeber MW, Marinovic J, Gutterman DD, Rakic M, Bosnjak ZJ, Stadnicka A: Age-related attenuation of isoflurane preconditioning in human atrial cardiomyo-cytes: Roles for mitochondrial respiration and sarcolem-mal adenosine triphosphate-sensitive potassium channel activity. ANESTHESIOLOGY 2008; 108:612-620
32. Sniecinski R, Liu H: Reduced efficacy of volatile anesthetic preconditioning with advanced age in isolated rat myocardium. ANESTHESIOLOGY 2004; 100:589-597
33. Tani M, Suganuma Y, Hasegawa H, Shinmura K, Ebihara Y, Hayashi Y, Guo X, Takayama M: Decrease in ischemic tolerance with aging in isolated perfused Fischer 344 rat hearts: Relation to increases in intracellular Na#sup#+#/sup# after ischemia. J Mol Cell Cardiol 1997; 29:3081-3089
34. Juhaszova M, Rabuel C, Zorov DB, Lakatta EG, Sollott SJ: Protection in the aged heart: Preventing the heart-break of old age? Cardiovasc Res 2005; 66:233-244
35. Huhn R, Heinen A, Weber NC, Hieber S, Hollmann MW, Schlack W, Preckel B: Helium-induced late preconditioning in the rat heart in vivo. Br J Anaesth 2009; 102:614-619
36. Weber NC, Frassdorf J, Ratajczak C, Grueber Y, Schlack W, Hollmann MW, Preckel B: Xenon induces late cardiac preconditioning in vivo: A role for cyclooxygenase 2? Anesth Analg 2008; 107:1807-1813
37. Wilhelm S, Ma D, Maze M, Franks NP: Effects of xenon on in vitro and in vivo models of neuronal injury. ANESTHESIOLOGY 2002; 96:1485-1491
38. Homi HM, Yokoo N, Ma D, Warner DS, Franks NP, Maze M, Grocott HP: The neuroprotective effect of xenon administration during transient middle cerebral artery occlusion in mice. ANESTHESIOLOGY 2003; 99:876-881
39. David HN, Haelewyn B, Rouillon C, Lecoq M, Chazalviel L, Apiou G, Risso JJ, Lemaire M, Abraini JH: Neuroprotective effects of xenon: A therapeutic window of opportunity in rats subjected to transient cerebral ischemia. FASEB J 2008; 22:1275-1286
40. Coburn M, Maze M, Franks NP: The neuroprotective effects of xenon and helium in an in vitro model of traumatic brain injury. Crit Care Med 2008; 36:588-595
41. Pan Y, Zhang H, VanDeripe DR, Cruz-Flores S, Panneton WM: Heliox and oxygen reduce infarct volume in a rat model of focal ischemia. Exp Neurol 2007; 205:587-590
42. Jawad N, Rizvi M, Gu J, Adeyi O, Tao G, Maze M, Ma D: Neuroprotection (and lack of neuroprotection) afforded by a series of noble gases in an in vitro model of neuronal injury. Neurosci Lett 2009; 460:232-236
43. VanDeripe DR: The swelling of mitochondria from nitrogen gas: A possible cause of reperfusion damage. Med Hypotheses 2004; 62:294-296
44. Barach AL: Use of heliox as a new therapeutic gas. Proc Soc Exp Bio Med 1934; 32:462-464
45. Rodrigo GPC, Rodrigo C, Rowe B, Walters EH: Heliox for treatment of exacerbations of chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2001; 1:CD003571
46. Rodrigo CPC, Rodrigo C, Rowe BH: Heliox for nonintu-bated acute asthma patients. Cochrane Database of Systematic Reviews 2006; 4:CD002884
47. Colebourn CL, Barber V, Young JD: Use of helium-oxygen mixture in adult patients presenting with exacerbations of asthma and chronic obstructive pulmonary disease: A systematic review. Anaesthesia 2007; 62:34-42
48. Nie M, Kobayashi H, Sugawara M, Tomita T, Ohara K, Yoshimura H: Helium inhalation enhances vasodilator effect of inhaled nitric oxide on pulmonary vessels in hy-poxic dogs. Am J Physiol Heart Circ Physiol 2001; 280: H1875-81
49. Lee DL, Hsu CW, Lee H, Chang HW, Huang YC: Beneficial effects of albuterol therapy driven by heliox versus by oxygen in severe asthma exacerbation. Acad Emerg Med 2005; 12:820-827
50. Kim IK, Phrampus E, Venkataraman S, Pitetti R, Saville A, Corcoran T, Gracely E, Funt N, Thompson A: Helium/oxygen-driven albuterol nebulization in the treatment of children with moderate to severe asthma exacerbations: A randomized, controlled trial. Pediatrics 2005; 116:1127-1133
51. Goode ML, Fink JB, Dhand R, Tobin MJ: Improvement in aerosol delivery with helium-oxygen mixtures during mechanical ventilation. Am J Respir Crit Care Med 2001; 163:109-114
52. Kress JP, Noth I, Gehlbach BK, Barman N, Pohlman AS, Miller A, Morgan S, Hall JB: The utility of albuterol nebulized with heliox during acute asthma exacerbations. Am J Respir Crit Care Med 2002; 165:1317-1321
53. Rivera ML, Kim TY, Stewart GM, Minasyan L, Brown L: Albuterol nebulized in heliox in the initial ED treatment of pediatric asthma: A blinded, randomized controlled trial. Am J Emerg Med 2006; 24:38-42
54. Henderson SO, Acharya P, Kilaghbian T, Perez J, Korn CS, Chan LS: Use of heliox-driven nebulizer therapy in the treatment of acute asthma. Ann Emerg Med 1999; 33: 141-146
55. Rose JS, Panacek EA, Miller P: Prospective randomized trial of heliox-driven continuous nebulizers in the treatment of asthma in the emergency department. J Emerg Med 2002; 22:133-137
56. Nawab US, Touch SM, Irwin-Sherman T, Blackson TJ, Greenspan JS, Zhu G, Shaffer TH, Wolfson MR: Heliox attenuates lung inflammation and structural alterations in acute lung injury. Pediatr Pulmonol 2005; 40:524-532
57. Sessler DI: Long-term consequences of anesthetic management. ANESTHESIOLOGY 2009; 111:1-4
58. Kooby DA: Laparoscopic pancreatic resection for cancer. Expert Rev Anticancer Ther 2008; 8:1597-1609
59. Kuhry E, Schwenk W, Gaupset R, Romild U, Bonjer J: Long-term outcome of laparoscopic surgery for colorectal cancer: A Cochrane systematic review of randomised controlled trials. Cancer Treat Rev 2008; 34:498-504
60. Buunen M, Veldkamp R, Hop WC, Kuhry E, Jeekel J, Haglind E, Pahlman L, Cuesta MA, Msika S, Morino M, Lacy A, Bonjer HJ: Survival after laparoscopic surgery versus open surgery for colon cancer: Long-term outcome of a randomised clinical trial. Lancet Oncol 2009; 10:44-52
61. Shen MY, Huang IP, Chen WS, Chang JT, Lin JK: Influence of pneumoperitoneum on tumor growth and pattern of intra-abdominal tumor spreading: In vivo study of a murine model. Hepatogastroenterology 2008; 55:947-951
62. Gutt CN, Gessmann T, Schemmer P, Mehrabi A, Schman-dra T, Kim ZG: The impact of carbon dioxide and helium insufflation on experimental liver metastases, macro-phages, and cell adhesion molecules. Surg Endosc 2003; 17:1628-1631
63. Jacobi CA, Ordemann J, Halle E, Volk HD, Muller JM: Impact of laparoscopy with carbon dioxide versus helium on local and systemic inflammation in an animal model of peritonitis. J Lapa-roendosc Adv Surg Tech A 1999; 9:305-312
64. Schmidt AI, Reismann M, Kubler JF, Vieten G, Bangen C, Shimotakahara A, Gluer S, Nustede R, Ure BM: Exposure to carbon dioxide and helium reduces in vitro proliferation of pediatric tumor cells. Pediatr Surg Int 2006; 22:72-77
65. Neuhaus SJ, Ellis T, Rofe AM, Pike GK, Jamieson GG, Watson DI: Tumor implantation following laparoscopy using different insufflation gases. Surg Endosc 1998; 12: 1300-1302 (Pubitemid 128531251)
66. Wong YT, Shah PC, Birkett DH, Brams DM: Peritoneal pH during laparoscopy is dependent on ambient gas environment: Helium and nitrous oxide do not cause peritoneal acidosis. Surg Endosc 2005; 19:60-64
67. Rosch R, Junge K, Binnebosel M, Mirgartz N, Klinge U, Schumpelick V: Improved abdominal wall wound healing by helium pneumoperitoneum. Surg Endosc 2006; 20: 1892-1896
68. Lucchinetti E, Wacker J, Maurer C, Keel M, Harter L, Zaugg K, Zaugg M: Helium breathing provides modest antiinflam-matory, but no endothelial protection against ischemia-reperfusion injury in humans in vivo. Anesth Analg 2009; 109:101-108
69. Pagel PS: Cardioprotection by noble gases. J Cardiothorac Vasc Anesth 2010; 24:143-163
70. Dahn S, Schwalbach P, Maksan S, Wohleke F, Benner A, Kuntz C: Influence of different gases used for laparoscopy (helium, carbon dioxide, room air, and xenon) on tumor volume, histomorphology, and leukocyte-tumor-endothe-lium interaction in intravital microscopy. Surg Endosc 2005; 19:65-70
71. Frassdorf J, De Hert S, Schlack W: Anaesthesia and myo-cardial ischaemia/reperfusion injury. Br J Anaesth 2009; 103:89-98
72. Pantos C, Mourouzis I, Cokkinos DV: Protection of the abnormal heart. Heart Fail Rev 2007; 12:319-330